- Home
- MEDP
as 10-17-2024 4:00pm EST
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Upcoming Earnings Alert:
Get ready for potential market movements as Medpace Holdings Inc. MEDP prepares to release earnings report on 21 Oct 2024.
| Founded: | 1992 | Country: | United States |
| Employees: | N/A | City: | CINCINNATI |
| Market Cap: | 11.7B | IPO Year: | 2016 |
| Target Price: | $402.44 | AVG Volume (30 days): | 385.5K |
| Analyst Decision: | Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 10.64 | EPS Growth: | 27.33 |
| 52 Week Low/High: | $227.21 - $459.77 | Next Earning Date: | 10-21-2024 |
| Revenue: | $2,030,048,000 | Revenue Growth: | 21.36% |
| Revenue Growth (this year): | 15.81% | Revenue Growth (next year): | 12.91% |
Stock Insider Trading Activity of Medpace Holdings Inc. (MEDP)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Kraft Robert O. | MEDP | Director | Aug 22 '24 | Sell | $390.73 | 8,127 | $3,175,462.71 | 520 |
Latest Medpace Holdings Inc. News
MEDP Breaking Stock News: Dive into MEDP Ticker-Specific Updates for Smart Investing
Simply Wall St.
8 hours ago
Do Medpace Holdings' (NASDAQ:MEDP) Earnings Warrant Your Attention?
Insider Monkey
a day ago
LVS Advisory Increased its Investment in Medpace (MEDP) in Q3
MT Newswires
4 days ago
Redburn Atlantic Initiates Medpace Holdings at Buy With $404 Price Target
Insider Monkey
8 days ago
Here’s Why Medpace (MEDP) Detracted in Q3
Argus Research
9 days ago
MEDP: Raising target price to $355.00
MT Newswires
21 days ago
UBS Downgrades Medpace Holdings to Neutral From Buy, Adjusts Price Target to $350 From $420
MT Newswires
22 days ago
Medpace Holdings Shares Fall After Downgrade From Jefferies
MT Newswires
23 days ago
Jefferies Downgrades Medpace Holdings to Hold From Buy, Price Target is $345
Compare MEDP vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MEDP Medpace Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.